rs2236017

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_181486.4(TBX5):​c.663+36G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.614 in 1,612,396 control chromosomes in the GnomAD database, including 308,823 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 25471 hom., cov: 31)
Exomes 𝑓: 0.62 ( 283352 hom. )

Consequence

TBX5
NM_181486.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:4

Conservation

PhyloP100: -0.956

Publications

14 publications found
Variant links:
Genes affected
TBX5 (HGNC:11604): (T-box transcription factor 5) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
TBX5 Gene-Disease associations (from GenCC):
  • Holt-Oram syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • heart conduction disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 12-114394705-C-A is Benign according to our data. Variant chr12-114394705-C-A is described in ClinVar as Benign. ClinVar VariationId is 139592.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.704 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBX5NM_181486.4 linkc.663+36G>T intron_variant Intron 6 of 8 ENST00000405440.7 NP_852259.1 Q99593-1
TBX5NM_000192.3 linkc.663+36G>T intron_variant Intron 6 of 8 NP_000183.2 Q99593-1
TBX5NM_080717.4 linkc.513+36G>T intron_variant Intron 5 of 7 NP_542448.1 Q99593-3
TBX5XM_017019912.2 linkc.711+36G>T intron_variant Intron 6 of 8 XP_016875401.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBX5ENST00000405440.7 linkc.663+36G>T intron_variant Intron 6 of 8 1 NM_181486.4 ENSP00000384152.3 Q99593-1

Frequencies

GnomAD3 genomes
AF:
0.569
AC:
86344
AN:
151822
Hom.:
25451
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.424
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.715
Gnomad ASJ
AF:
0.618
Gnomad EAS
AF:
0.346
Gnomad SAS
AF:
0.674
Gnomad FIN
AF:
0.619
Gnomad MID
AF:
0.652
Gnomad NFE
AF:
0.624
Gnomad OTH
AF:
0.589
GnomAD2 exomes
AF:
0.619
AC:
155374
AN:
251088
AF XY:
0.622
show subpopulations
Gnomad AFR exome
AF:
0.417
Gnomad AMR exome
AF:
0.795
Gnomad ASJ exome
AF:
0.617
Gnomad EAS exome
AF:
0.337
Gnomad FIN exome
AF:
0.619
Gnomad NFE exome
AF:
0.628
Gnomad OTH exome
AF:
0.603
GnomAD4 exome
AF:
0.619
AC:
904338
AN:
1460456
Hom.:
283352
Cov.:
39
AF XY:
0.620
AC XY:
450819
AN XY:
726584
show subpopulations
African (AFR)
AF:
0.415
AC:
13863
AN:
33444
American (AMR)
AF:
0.782
AC:
34954
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.620
AC:
16204
AN:
26116
East Asian (EAS)
AF:
0.364
AC:
14427
AN:
39684
South Asian (SAS)
AF:
0.670
AC:
57725
AN:
86212
European-Finnish (FIN)
AF:
0.611
AC:
32525
AN:
53232
Middle Eastern (MID)
AF:
0.594
AC:
3413
AN:
5748
European-Non Finnish (NFE)
AF:
0.626
AC:
695427
AN:
1110978
Other (OTH)
AF:
0.593
AC:
35800
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
15949
31899
47848
63798
79747
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18512
37024
55536
74048
92560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.569
AC:
86413
AN:
151940
Hom.:
25471
Cov.:
31
AF XY:
0.573
AC XY:
42549
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.424
AC:
17552
AN:
41406
American (AMR)
AF:
0.715
AC:
10927
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.618
AC:
2138
AN:
3462
East Asian (EAS)
AF:
0.347
AC:
1786
AN:
5140
South Asian (SAS)
AF:
0.674
AC:
3239
AN:
4806
European-Finnish (FIN)
AF:
0.619
AC:
6537
AN:
10568
Middle Eastern (MID)
AF:
0.660
AC:
194
AN:
294
European-Non Finnish (NFE)
AF:
0.624
AC:
42409
AN:
67964
Other (OTH)
AF:
0.589
AC:
1245
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1856
3712
5568
7424
9280
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
736
1472
2208
2944
3680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.552
Hom.:
7981
Bravo
AF:
0.566

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Molecular Genetics and Enzymology, National Research Centre
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holt-Oram syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.18
DANN
Benign
0.60
PhyloP100
-0.96
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2236017; hg19: chr12-114832510; COSMIC: COSV59860963; COSMIC: COSV59860963; API